The extended credit facility removes near-term refinancing risk and provides committed liquidity through 2031. Monitor upcoming quarterly filings for leverage ratio and covenant compliance, as the reduced facility size may signal conservative capital management. No immediate catalyst for stock movement.
ANIK drugs
ANIK drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jul 15 $15.93entry
- T+1 · 4mo ago −0.69%α −0.15% · $15.82
- T+5 · 4mo ago −5.78%α −4.79% · $15.01
- T+20 · 3mo ago +38.29%α +35.95% · $22.03
- T+60 · 6w ago +20.72%α +18.18% · $19.23
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Anika Therapeutics entered into a Fifth Amendment to its existing credit agreement with Bank of America on July 10, 2026, reducing the revolving facility to $50 million and extending the maturity to July 10, 2031. The amendment includes a potential $50 million accordion feature, SOFR-based pricing with a spread of 0.25%-1.25%, and financial covenants (max leverage 3.50x, min interest coverage 3.00x). This is a routine refinancing that provides extended liquidity without material new financial data.
Key Facts
- Revolving credit facility reduced to $50 million (from an undisclosed prior amount) with a maturity date of July 10, 2031.
- Company may request up to an additional $50 million in commitments, subject to lender approval, for a maximum of $100 million.
- Interest rate is SOFR plus 0.25% to 1.25% based on consolidated leverage ratio; commitment fee is 0.20% to 0.30% per annum.
- Financial covenants: maximum Consolidated Net Leverage Ratio of 3.50x (stepping to 4.00x for material acquisitions) and minimum Consolidated Interest Coverage Ratio of 3.00x.
- Lenders hold a first-priority lien on substantially all assets of the company.
Financial Impact
No new borrowing or financial figures disclosed; facility size reduced to $50 million with extended maturity.
Risk Factors
- Potential covenant breach if leverage increases above 3.50x or interest coverage falls below 3.00x.
- Interest rate exposure from SOFR-based floating rate pricing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (ANIK), Batch item 1 | 0001171843-26-004635 |
| Exhibit: exh_102.htm | 0001171843-26-004635 |
| Document: f8k_071426.htm | 0001171843-26-004635 |
| Document: 0001171843-26-004635-index-headers.html | 0001171843-26-004635 |
| Document: 0001171843-26-004635-index.html | 0001171843-26-004635 |
| Document: 0001171843-26-004635.txt | 0001171843-26-004635 |
| 8-K Filing (ANIK), Batch item 7 | 0001171843-26-004635 |
Track record
13 reports on ANIK
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 6, 202610d ago 8-K Mixed 6/10 Entry $14.55 Now $12.92 −11.20% settles Feb 4
- Oct 22, 202625d ago Press Release Neutral 1/10 Entry $21.42 Now $12.92 −39.68% settles Jan 21
- Jul 29, 202615w ago 8-K Bullish 8/10 Entry $16.17 to $21.09 Now $12.92 −20.10% ▲ +30.43% +25.70% vs SPY
- Jul 14, 202617w ago 8-K Neutral 3/10 Viewing Entry $15.93 to $19.23 Now $12.92 −18.90% ▲ +20.72% +18.18% vs SPY
- Jun 23, 202620w ago 8-K Neutral 4/10 Entry $14.73 to $21.03 Now $12.92 −12.29% ▲ +42.77% +39.93% vs SPY
- Jun 11, 202622w ago Institutional Cluster Bearish 4/10 Entry $14.72 to $21.04 Now $12.92 +12.23% ▼ −42.93% −39.67% vs SPY
- Jun 8, 202623w ago DEFA14A Neutral 4/10 Entry $14.60 to $21.11 Now $12.92 −11.51% ▲ +44.59% +41.54% vs SPY
- Jun 1, 202624w ago DEFA14A Neutral 3/10 Entry $14.63 to $21.40 Now $12.92 −11.69% ▲ +46.27% +45.04% vs SPY
- Apr 30, 202628w ago Insider Cluster Mixed 5/10 Entry $14.85 to $16.17 Now $12.92 −13.00% ▲ +8.89% +7.41% vs SPY
- Apr 29, 202628w ago 8-K Mixed 6/10 Entry $12.39 to $14.95 Now $12.92 +4.28% ▲ +20.66% +16.55% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers